ESMO 2022: EV Pembrolizumab in 1st line bladder cancer

Peter O'Donnell describes the study. 

2356 232

Suggested Podcasts

Dallas Taylor

The Washington Post

The Hollywood Reporter

Tom Merritt

Anne Bogel

Justin Lore

The Horse: Your Guide to Equine Health Care

Azmeen Aga